The 4 most recent market catalysts affecting $ZBH, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110
RBC Capital's analyst Shagun Singh maintained an 'Outperform' rating on Zimmer Biomet Holdings (ZBH) and raised the price target from $101 to $110. This action signals continued co…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 85
Zimmer Biomet Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
This headline represents a significant corporate catalyst for Zimmer Biomet. Better-than-expected earnings and raised guidance are strong indicators of fundamental strength and imp…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 92
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate
Zimmer Biomet Holdings (ZBH) announced Q2 adjusted EPS of $2.07, surpassing the analyst consensus of $2.01, and sales of $2.177 billion, exceeding the $2.134 billion estimate. This…
Jul 13, 2026
Corporate Catalyst
Neutral
Impact 75
Live On CNBC, Sarat Sethi Announces Sold Zimmer Biomet
Sarat Sethi, a well-known analyst, publicly announcing the sale of Zimmer Biomet (ZBH) on CNBC is a significant event for the company and its investors. This could signal a loss of…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.